The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Gergen Mark J since year 2005.
The trader's CIK number is 1373110.
At the time of this reporting, Gergen Mark J is the Executive VP, COO of Mirati Therapeutics, Inc. .
(stock ticker symbol MRTX).
See this page for all insider trading activities at Mirati Therapeutics, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2016-01-15 | MRTX | Mirati Therapeutics, Inc. | Option Ex | 15,000 | 8.50 | 127,500 |
| 2016-01-15 | MRTX | Mirati Therapeutics, Inc. | Sale | 10,000 | 25.92 | 259,210 |
| 2012-03-01 | AMLN | Amylin Pharmaceuticals Inc | Sale | 1,846 | 17.11 | 31,585 |
| 2012-02-23 | AMLN | Amylin Pharmaceuticals Inc | Sale | 7,518 | 17.03 | 128,031 |
| 2007-11-01 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-11-01 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 44.00 | 22,000 |
| 2007-10-03 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-10-03 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 50.00 | 25,000 |
| 2007-10-01 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 49.83 | 24,915 |
| 2007-10-01 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-09-04 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 1,000 | 16.80 | 16,800 |
| 2007-09-04 | AMLN | Amylin Pharmaceuticals Inc | Sale | 1,000 | 49.50 | 49,500 |
| 2007-08-07 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-08-07 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 50.00 | 25,000 |
| 2007-08-01 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 46.50 | 23,250 |
| 2007-08-01 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-07-24 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-07-24 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 45.00 | 22,500 |
| 2007-07-02 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-07-02 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 41.20 | 20,600 |
| 2007-06-01 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 1,000 | 16.80 | 16,800 |
| 2007-06-01 | AMLN | Amylin Pharmaceuticals Inc | Sale | 1,000 | 46.16 | 46,160 |
| 2007-05-21 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-05-21 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 45.00 | 22,500 |
| 2007-05-01 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 41.25 | 20,625 |
| 2007-05-01 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-04-02 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 37.47 | 18,735 |
| 2007-04-02 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-03-01 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-03-01 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 37.75 | 18,875 |
| 2007-02-01 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-02-01 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 38.75 | 19,375 |
| 2007-01-03 | AMLN | Amylin Pharmaceuticals Inc | Option Ex | 500 | 16.80 | 8,400 |
| 2007-01-03 | AMLN | Amylin Pharmaceuticals Inc | Sale | 500 | 36.29 | 18,145 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gergen Mark J (Executive VP, COO of Mirati Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.